TGen Identifies Immune Effects Of Drug In Aggressive Ovarian Cancer Striking Young Women
A study published by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, in the scientific journal PLOS ONE, has revealed that a drug known as SP-2577…
Share